EHR · Patient data

How much does pharma pay for EHR data

Anshuman Sharma Tech Entrepreneur

December 11th, 2013

I have been trying to get some data points (or even a range) on the value of EHR data to pharma companies. There is enough articles that highlight that pharma companies acquire this data through providers or EHR companies directly. I also realize that this may vary across disease states. But it would be good to get input on folks on the pharma-side or the EHR data sales side to validate with a range (in terms of per patient value).

Anshuman Sharma Tech Entrepreneur

December 11th, 2013

RIght, I do understand that it is indication dependent. However, what I was trying to do was get some empirical evidence. Such as (say hypothetically) - $50/patient/year for something like respiratory/asthma -  $150/patient/year for oncology.

I know that pharma buys data from PBMs, providers or directly from EHR companies (de-identified of course).

Mitchell Portnoy Healthcare Information Executive

December 11th, 2013

My experience is that the value of the data is in the context for which the drug claims are ordered by the provider - namely disease state. Big pharma typically purchases point of care data either directly from pharmacy swipe readers, including Wallgreen's etc., or prefers to have a complete, but de-identififed pharmacy and medical claims integrated database which may or may not include a transformational layer, eg., Episode Treatment Groups.  

Hope this helps even if I'm not answering or exact question.